Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H14N4O2S |
Molecular Weight | 302.352 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC(=O)NC1=CC=C2N=C(NC2=C1)C3=CSC=N3
InChI
InChIKey=QZWHWHNCPFEXLL-UHFFFAOYSA-N
InChI=1S/C14H14N4O2S/c1-8(2)20-14(19)16-9-3-4-10-11(5-9)18-13(17-10)12-6-21-7-15-12/h3-8H,1-2H3,(H,16,19)(H,17,18)
Cambendazole is a veterinary anti-parasitic drug, which was approved by FDA for the treatment of worm infections in horses. The mode of action of cambendazole is the inhibition of glucose uptake, fumarate reductase and phosphoenolpyruvate carboxykinase. Due to its mechanism of action, cambendazole causes the paralysis of parasites.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Parasitic phosphoenolpyruvate carboxykinase |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | CAMVET Approved UseIt is used in horses for the control of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles (Trichonema, Poteriostomum, Cylicobrachytus, Craterostomum, Oesophagodontus); roundworms (Parascaris); pinworms (Oxyuris); and threadworms (Strongyloides). |
PubMed
Title | Date | PubMed |
---|---|---|
In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives. | 1997 Dec |
|
Population-S benzimidazole- and tetrahydropyrimidine-resistant small strongyles in a pony herd in Kentucky (1977-1999): effects of anthelmintic treatment on the parasites as determined in critical tests. | 2003 Nov |
|
Comparison of multivariate calibration methods to determine simultaneously mebendazole-cambendazole and mebendazole-thiabendazole in pharmaceutical preparations by UV-visible spectrophotometry. | 2003 Nov 24 |
|
Replacement of the essential Dictyostelium Arp2 gene by its Entamoeba homologue using parasexual genetics. | 2007 Jun 6 |
Sample Use Guides
It is administered by stomach tube or as a drench at a dose of 0.9 gram of cambendazole per 100 pounds of body weight (20 milligrams per kilogram).
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.scielo.br/pdf/rimtsp/v28n2/06.pdf
Thirty-two small watch glasses were each set up with 100 ug aliquots of feces containing eggs of S.ratti. To each of these was added 400 uL PBS
containing either no drug or 200 ug of cambendazole giving a final concentration of 400 ug drug/ml. There was a 52% reduction
in the numbers of first-stage larvae in feces incubated with cambendazole for seven hours. After 24 hours incubation with drug (48 hours after feces were moistened) no viable infective larvae were seen in feces.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.284B
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
||
|
CFR |
21 CFR 520.284A
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
||
|
WHO-VATC |
QP52AC08
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
||
|
CFR |
21 CFR 520.284C
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
||
|
CFR |
21 CFR 520.284
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000081616
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
CHEMBL290578
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
DTXSID0046852
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
D002159
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
DB11380
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
079X63S3DU
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
2931
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
247-459-5
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
26097-80-3
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
C75212
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
1951
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB06062MIG
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
m2998
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | Merck Index | ||
|
377071
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY | |||
|
33309
Created by
admin on Sat Dec 16 16:52:36 UTC 2023 , Edited by admin on Sat Dec 16 16:52:36 UTC 2023
|
PRIMARY |
ACTIVE MOIETY